Anders Nørkær Jørgensen

Anders Nørkær Jørgensen is a Senior Clinical Scientist with experience in managing and conducting clinical trials in rare diseases such as achondroplasia and sporadic inclusion body myositis. Anders has worked at companies like Ascendis Pharma, Orphazyme A/S, and Novo Nordisk, where Anders has gained expertise in trial planning, data oversight, and scientific communication. With a background in sports and exercise science, Anders has also taught and examined students in topics related to physiology, strength training, and physical performance optimization. Additionally, Anders has a PhD in the rehabilitation of inclusion body myositis patients and a diverse educational background in sports science and rehabilitation.